These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31545503)

  • 1. Diagnostic and prognostic values of C‑X‑C motif chemokine ligand 3 in patients with colon cancer.
    Ruan GT; Gong YZ; Liao XW; Wang S; Huang W; Wang XK; Zhu GZ; Liao C; Gao F
    Oncol Rep; 2019 Nov; 42(5):1996-2008. PubMed ID: 31545503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated expression of CXCL3 in colon cancer promotes malignant behaviors of tumor cells in an ERK-dependent manner.
    Cheng Y; Yang X; Liang L; Xin H; Dong X; Li W; Li J; Guo X; Li Y; He J; Zhang C; Wang W
    BMC Cancer; 2023 Nov; 23(1):1162. PubMed ID: 38031087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression and methylation profiles identified CXCL3 and CXCL8 as key genes for diagnosis and prognosis of colon adenocarcinoma.
    Zhao QQ; Jiang C; Gao Q; Zhang YY; Wang G; Chen XP; Wu SB; Tang J
    J Cell Physiol; 2020 May; 235(5):4902-4912. PubMed ID: 31709538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a CXC Chemokine-Based Prediction Model for the Prognosis of Colon Cancer.
    Liu K; Lai M; Wang S; Zheng K; Xie S; Wang X
    Biomed Res Int; 2020; 2020():6107865. PubMed ID: 32337262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance and biological functions of chemokine CXCL3 in head and neck squamous cell carcinoma.
    Guan J; Weng J; Ren Q; Zhang C; Hu L; Deng W; Lu S; Dong X; Li W; Li Y; Wang W
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34870709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL3 overexpression promotes the tumorigenic potential of uterine cervical cancer cells via the MAPK/ERK pathway.
    Qi YL; Li Y; Man XX; Sui HY; Zhao XL; Zhang PX; Qu XS; Zhang H; Wang BX; Li J; Qi SF; Jia LL; Luan HY; Zhang CB; Wang WQ
    J Cell Physiol; 2020 May; 235(5):4756-4765. PubMed ID: 31667838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression levels of chemokine (C-X-C motif) ligands CXCL1 and CXCL3 as prognostic biomarkers in rectal adenocarcinoma: evidence from Gene Expression Omnibus (GEO) analyses.
    Lv QY; Zou HZ; Xu YY; Shao ZY; Wu RQ; Li KJ; Deng X; Gu DN; Jiang HX; Su M; Zou CL
    Bioengineered; 2021 Dec; 12(1):3711-3725. PubMed ID: 34269159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma CXCL3 Levels Are Associated with Tumor Progression and an Unfavorable Colorectal Cancer Prognosis.
    Cui C; Zhang R; Gu F; Pei Y; Sun L; Huang Y; Niu G; Li J
    J Immunol Res; 2022; 2022():1336509. PubMed ID: 35664357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Chemokine CXCL16 Is a New Biomarker for Lymph Node Analysis of Colon Cancer Outcome.
    AbdelMageed M; Ali H; Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31752131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine CXCL3 mediates prostate cancer cells proliferation, migration and gene expression changes in an autocrine/paracrine fashion.
    Xin H; Cao Y; Shao ML; Zhang W; Zhang CB; Wang JT; Liang LC; Shao WW; Qi YL; Li Y; Zhang ZY; Yang Z; Sun YH; Zhang PX; Jia LL; Wang WQ
    Int Urol Nephrol; 2018 May; 50(5):861-868. PubMed ID: 29524043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXC chemokines located in the 4q21 region are up-regulated in breast cancer.
    Bièche I; Chavey C; Andrieu C; Busson M; Vacher S; Le Corre L; Guinebretière JM; Burlinchon S; Lidereau R; Lazennec G
    Endocr Relat Cancer; 2007 Dec; 14(4):1039-52. PubMed ID: 18045955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The myeloid cell biomarker EMR1 is ectopically expressed in colon cancer.
    Ali H; Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
    Tumour Biol; 2021; 43(1):209-223. PubMed ID: 34486997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic values of integrin α subfamily mRNA expression in colon adenocarcinoma.
    Gong YZ; Ruan GT; Liao XW; Wang XK; Liao C; Wang S; Gao F
    Oncol Rep; 2019 Sep; 42(3):923-936. PubMed ID: 31322253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of CXCL3 can enhance the oncogenic potential of prostate cancer.
    Gui SL; Teng LC; Wang SQ; Liu S; Lin YL; Zhao XL; Liu L; Sui HY; Yang Y; Liang LC; Wang ML; Li XY; Cao Y; Li FY; Wang WQ
    Int Urol Nephrol; 2016 May; 48(5):701-9. PubMed ID: 26837773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines.
    Sun X; Chen Q; Zhang L; Chen J; Zhang X
    Math Biosci Eng; 2021 Jul; 18(5):6262-6287. PubMed ID: 34517533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent prognostic genes and mechanism investigation for colon cancer.
    Li C; Shen Z; Zhou Y; Yu W
    Biol Res; 2018 Apr; 51(1):10. PubMed ID: 29653552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role and clinicopathologic significance of CXC chemokine ligand 16 and chemokine (C-X-C motif) receptor 6 expression in gastric carcinomas.
    Xing YN; Xu XY; Nie XC; Yang X; Yu M; Xu HM; Liu YP; Takano Y; Zheng HC
    Hum Pathol; 2012 Dec; 43(12):2299-307. PubMed ID: 22863086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance and prospective molecular mechanism of C‑C motif chemokine receptors in patients with early‑stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.
    Zhou X; Liao X; Wang X; Huang K; Yang C; Yu T; Liu J; Han C; Zhu G; Su H; Qin W; Han Q; Liu Z; Huang J; Gong Y; Ye X; Peng T
    Oncol Rep; 2019 Nov; 42(5):1856-1868. PubMed ID: 31432181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of the clinical and biological significances for chemokine CXCL3 in cholangiocarcinoma.
    Ren H; Yang X; Hou W; Meng J; Luo D; Zhang C
    Medicine (Baltimore); 2024 Mar; 103(11):e37460. PubMed ID: 38489741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.